88IV - PR Newswire Asia's news


Tescan Opens New Demo Lab in Korea to Support Semiconductor Failure Analysis, Reliability, and Academic Research Across Asia-Pacific Integrated demo lab and office site brings demonstrations, training, and workflow support closer to semiconductor and academic users across APAC . ... 2026-03-20T Biotechnology Computer/Electronics Semiconductors
Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs SUZHOU, China and MÖLNDAL, Sweden , March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences SINGAPORE , March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the ... 2026-03-20T Biotechnology Education Health Care/Hospital Higher Education
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016 SUZHOU, China , March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session SHANGHAI , March 20, 2026 /PRNewswire/ -- D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Bambusa Therapeutics Appoints Todd James Chief Financial Officer - Mr. James brings more than 20 years of biopharmaceutical leadership experience, with deep expertise in capital markets, investor relations, and corporate strategy, serving in senior executive roles at ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ractigen Therapeutics Announces China NMPA IND Approval for Phase II Clinical Trial of saRNA Therapy RAG-01 in Non-Muscle Invasive Bladder Cancer NANTONG, China , March 19, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China SHANGHAI , March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 19, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology